AUTOMATED HOLLOW FIBER BIOREACTOR CONTROL SYSTEM

Information

  • Research Project
  • 2183300
  • ApplicationId
    2183300
  • Core Project Number
    R43GM045630
  • Full Project Number
    1R43GM045630-01
  • Serial Number
    45630
  • FOA Number
  • Sub Project Id
  • Project Start Date
    3/1/1992 - 32 years ago
  • Project End Date
    8/31/1992 - 32 years ago
  • Program Officer Name
  • Budget Start Date
    3/1/1992 - 32 years ago
  • Budget End Date
    8/31/1992 - 32 years ago
  • Fiscal Year
    1992
  • Support Year
    1
  • Suffix
  • Award Notice Date
    2/27/1992 - 32 years ago
Organizations

AUTOMATED HOLLOW FIBER BIOREACTOR CONTROL SYSTEM

This research objective is to test the efficacy of a new design of hollow fiber bioreactor for mammalian cell culture, and an integrated automated bioreactor control system. This research will investigate a hollow fiber bioreactor with optimized critical diffusional geometries combined with an integrated control system prototype which has Ph and dissolved oxygen (DO) monitoring and control capabilities. The bioreactor design uses concentric fibers to keep all cells immobilized within 200 microns of a diffusional oxygen source, and has supported hybridomas at high density (> 10/ml) and high viability ( > 85%) for 30 days. The system eliminates many failure modes of conventional hollow fiber reactors including bioreactor diffusional gradients, system autoclavability, peristaltic pump failure, and lack of Ph and DO controls. There are numerous diagnostic and therapeutic applications for developing in vitro cell culture methods and tissue models. There is a rapidly expanding market for cell culture equipment especially for the production of monoclonal antibodies (Mabs) and other secreted products. This market is actively pursuing alternatives to animals especially for therapeutic products. The goal of this research is to provide this market with a complete, compact, turnkey system for mammalian cell culture which is affordable ($12-15K), easy to use, and which solves many key failure modes of conventional reactor systems. This type of system could be used to produce 1-10 gram quantities of secreted products, cells for harvest or in vitro tissue analysis, and to optimize cell culture conditions.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    SETEC, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    LIVERMORE
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    945503848
  • Organization District
    UNITED STATES